Allarity Therapeutics Publishes Interim Report for the Period January – June 2021

NEXT STORY
Amarin Reports Data from REDUCE-IT® Showing VASCEPA®/VAZKEPA (Icosapent Ethyl) Significantly Reduces Ischemic Events in Patients with Prior Heart Attacks Presented in Late Breaking Science Session at ESC Congress 2021, Organized by the European Society of Cardiology
PREV STORY
HUTCHMED Selected as Constituent of Certain Hang Seng Indexes
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innate Pharma: Jennifer Butler appointed as Executive VP, General Manager, US

author_avatar
NASDAQ Market News

CareDx Drives Personalized Medicine in Transplantation at CEOT

author_avatar
NASDAQ Market News

CLS Presents MRI-Guided, Laser Ablation Solutions for Prostate Cancer at CME-Accredited Conferences in London, Paris & Amsterdam

author_avatar
NASDAQ Market News